Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337744516> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2337744516 endingPage "9" @default.
- W2337744516 startingPage "794" @default.
- W2337744516 abstract "To evaluate the efficacy and safety of a once daily valsartan/amlodipine 80/5 mg combination tablet in Chinese mild to moderate hypertensive patients without adequate blood pressure control by monotherapy.Two multicenter, randomized, double-blind, double dummy, active-controlled, parallel group trials were conducted. After a washout period (no medication) of 1-4 weeks, patients with Mean Sitting Diastolic Blood Pressure (MSDBP) > or = 95 mm Hg (1 mm Hg = 0.133 kPa) and < 110 mm Hg received a monotherapy of either Amlodipine 5 mg (in study 1) or valsartan 80 mg (in study 2) for 4 weeks. Patients with MSDBP > or = 90 mm Hg and < 110 mm Hg at the end of the monotherapy period were randomized to receive valsartan/amlodipine 80/5 mg treatment, or continue with the monotherapy.In study 1, compared with amlodipine 5 mg, valsartan/amlodipine 80/5 mg once daily further reduced mean sitting systolic blood pressure (MSSBP)/MSDBP 4.4/3 mm Hg (P < 0.0001). In study 2, compared with valsartan 80 mg, valsartan/amlodipine 80/5 mg once daily further reduced MSSBP/MSDBP 6.4/4.2 mm Hg (P < 0.0001). The blood pressure (BP) control rates (BP < 140/90 mm Hg) of combination treatment group were 71.0% and 71.2% respectively, and significantly higher than the monotherapy groups in both trials. Incidence of adverse events was comparable in monotherapy and combination therapy groups.Our results showed that valsartan/amlodipine 80/5 mg was superior to amlodipine 5 mg or valsartan 80 mg alone in lowering blood pressure and BP control in patients with mild to moderate hypertension not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. No new or unexpected safety issues were identified with valsartan/amlodipine combination therapy compared with monotherapy." @default.
- W2337744516 created "2016-06-24" @default.
- W2337744516 creator A5030040961 @default.
- W2337744516 creator A5055481715 @default.
- W2337744516 creator A5089532723 @default.
- W2337744516 date "2009-09-01" @default.
- W2337744516 modified "2023-09-27" @default.
- W2337744516 title "[Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy]." @default.
- W2337744516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20128376" @default.
- W2337744516 hasPublicationYear "2009" @default.
- W2337744516 type Work @default.
- W2337744516 sameAs 2337744516 @default.
- W2337744516 citedByCount "4" @default.
- W2337744516 countsByYear W23377445162013 @default.
- W2337744516 countsByYear W23377445162015 @default.
- W2337744516 countsByYear W23377445162016 @default.
- W2337744516 crossrefType "journal-article" @default.
- W2337744516 hasAuthorship W2337744516A5030040961 @default.
- W2337744516 hasAuthorship W2337744516A5055481715 @default.
- W2337744516 hasAuthorship W2337744516A5089532723 @default.
- W2337744516 hasConcept C126322002 @default.
- W2337744516 hasConcept C126894567 @default.
- W2337744516 hasConcept C197934379 @default.
- W2337744516 hasConcept C2776999253 @default.
- W2337744516 hasConcept C2777097880 @default.
- W2337744516 hasConcept C2777387769 @default.
- W2337744516 hasConcept C2779646130 @default.
- W2337744516 hasConcept C71924100 @default.
- W2337744516 hasConcept C84393581 @default.
- W2337744516 hasConcept C98274493 @default.
- W2337744516 hasConceptScore W2337744516C126322002 @default.
- W2337744516 hasConceptScore W2337744516C126894567 @default.
- W2337744516 hasConceptScore W2337744516C197934379 @default.
- W2337744516 hasConceptScore W2337744516C2776999253 @default.
- W2337744516 hasConceptScore W2337744516C2777097880 @default.
- W2337744516 hasConceptScore W2337744516C2777387769 @default.
- W2337744516 hasConceptScore W2337744516C2779646130 @default.
- W2337744516 hasConceptScore W2337744516C71924100 @default.
- W2337744516 hasConceptScore W2337744516C84393581 @default.
- W2337744516 hasConceptScore W2337744516C98274493 @default.
- W2337744516 hasIssue "9" @default.
- W2337744516 hasLocation W23377445161 @default.
- W2337744516 hasOpenAccess W2337744516 @default.
- W2337744516 hasPrimaryLocation W23377445161 @default.
- W2337744516 hasRelatedWork W1996206510 @default.
- W2337744516 hasRelatedWork W2030083921 @default.
- W2337744516 hasRelatedWork W2048583251 @default.
- W2337744516 hasRelatedWork W2058889794 @default.
- W2337744516 hasRelatedWork W2088035309 @default.
- W2337744516 hasRelatedWork W2337744516 @default.
- W2337744516 hasRelatedWork W2350587434 @default.
- W2337744516 hasRelatedWork W2360314475 @default.
- W2337744516 hasRelatedWork W2391072036 @default.
- W2337744516 hasRelatedWork W4221071113 @default.
- W2337744516 hasVolume "37" @default.
- W2337744516 isParatext "false" @default.
- W2337744516 isRetracted "false" @default.
- W2337744516 magId "2337744516" @default.
- W2337744516 workType "article" @default.